|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Metformin effect on clinical features,endocrine and metabolic profiles and insulin sensitivity in polycystic ovary syndrome: a randomized, double blind, placebo-controlled 6-month trail, followed by open, long-term clinical evaluation 显示文摘 | Moghetti P Castello R Negri C | 2000 | Clin Endocrinol Metab2000，85，： | 1 |
| 2 | Treatment of polycystic ovary syndrome with spironolactone plus licorice显示文摘 | Armanini D Castello R Scaroni C | 2007 | Obstet Gynecol Reprod Biol2007，131，1： | 1 |
| 3 | Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double blind, placebo controlled 6-month trial, followed by open, long-term clinical evaluation 显示文摘 | Moghetti P Castello R Negri C | 2000 | J Clin Endocrinol Metab2000，85，1： | 1 |
| 4 | Metformin effects on clinical features,endocrine and metabolic profiles,and insulin sensitivity in polycystic ovary syndrome:a randomized,double-blind,placebo-controlled 6-month trial,followed by open,long-term clinical evaluation显示文摘 | Moghetti P Castello R Negri C | 2000 | J Clin Endocrinol Metab2000，85，1： | 1 |
| 5 | Odd-harmonic digital repet itive control ofasingle-phase current active filter显示文摘 | Castello R C Grino R Fossas E | | 0，，04： | 1 |
| 6 | Quant-itative real-time reverse transcription-PCR assay forurokinase Plasminogen activator, Plasminogen activatorinhibitor tyPel ,and tissue metalloproteinase inhibitor type1 gene expressions in Primary breast cancer 显示文摘 | CASTELLO R ESTELLES A VAZQUEZ C | 2002 | ClinChem2002，48，8： | 1 |
| 7 | Modulation of hydrogen per- oxide production in cellular systems by low level magnet- ic fields 显示文摘 | Martino C F Castello P R | 2011 | PLOS ONE2011，6，22： | 1 |
| 8 | Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator,plasminogen activator inhibitor type 1,and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer显示文摘 | CASTELLO R ESTELLES A VAZQUEZ C | 2002 | Clin Chem2002，48，8： | 1 |
| 9 | Quantitative real - time reverse transcription - PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer 显示文摘 | Castello R Estelles A Vazquez C | 2002 | Clin Chem2002，48，8： | 1 |
| 10 | Treatment of polycystic ovarysyndrome with spironolactone plus licorice 显示文摘 | Armanini D Castello R Scaroni C | 2007 | Eur J Obstet Gynecol Reprod Biol2007，131，1： | 1 |
| 11 | Metformin effects on clinical features,endocrine and metabolic profiles,and insulin insulin sensitity in polycystic ovary synsdrom:a randomized,double-blind, placebo-controlled 6-month trial,followed by open, long-term clinical evaluation显示文摘 | Moghetti P Castello R Negri C | 2000 | J Clin Endocrinol Metab2000，85，： | 1 |
| 12 | Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator,plasminogen activator inhibitor type 1,and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer显示文摘 | Castello R Estelles B Vazquez C | 2002 | Clin Chemistry2002，48，8： | 1 |
| 13 | Metformin effects on clinical features,endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation 显示文摘 | Moghetti P Castello R Negri C | 2000 | J Clin Endocrinol Metab2000，85，1： | 1 |
| 14 | Flutamide in treatment of hirsutism: long- term clinical effects, endocrine changes, and androgen receptor behavior 显示文摘 | Moghetti P Castello R Negri C | 1995 | Fertil Steril1995，64，3： | 1 |
| 15 | Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation 显示文摘 | Moghetti P Castello R Negri C | 2000 | J Clin Endocrinol Metab2000，85，1： | 1 |
| 16 | Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open,long-term clinical evaluation显示文摘 | Moghetti P Castello R Negri C | 2000 | J Clin Endocrinol Metab2000，85，： | 1 |
| 17 | Metfonnin effects on clinical features,endocrine and metabolic profiles,and insulin sensitivity in polycystic ovary syndrome:a randomized,double-blind,placebo-controlled 6-month trial,followed by open,long-term clinical evaluation显示文摘 | Moghtti P Castello R Negri C | 2000 | J Clin Endocrinol Metab2000，85，1： | 1 |
| 18 | Plasminogen activator inhibitor-1 4G/SG polymorphiam in breast cancer patients and its association with tissue PAI-1 levels and tumor severity显示文摘 | Castello R Espana F Vazquez C | 2005 | Thromb Res2005，19，： | 1 |
| 19 | Metfomin effects on clinical features,endocrine and metabolic profiles,and insulin sensitivity in polycystic ovary syndrome:a randomized,double-blind placebo-controlle 6-month trial,followed by open,long-term clinical evaluation显示文摘 | Moghetti P Castello R Negri C | 2000 | J Clin Endocrinol Metab2000，85，1： | 1 |
| 20 | Atrial spetal aneurysm and stroke : a transesophageal echoeardiographic study 显示文摘 | Pearson A C Nagelhout D Castello R | 1991 | J Am Coll Cardiol1991，18，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员